Myanmar - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, Myanmar Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis grew 0.7points year on year. At 83 Percent in 2019, the country was ranked number 72 comparing other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis. Norway lead the ranking with 108 Percent in 2019, that is a growth of 2.9points compared to 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea recorded the best 5 years average growth at +34.3points per year, while United Arab Emirates witnessed the worst performance at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 83.00 |
| 2018 | 82.00 |
| 2017 | 82.00 |
| 2016 | 81.00 |
| 2015 | 80.00 |
Download all data from 2009 to 2019
How does Myanmar rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
| # | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
| 2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
| 72 |
#72
Guinea
|
83.00 % | 2019 | +1.2 % | +2.0 % | View data | |
| 72 |
#72
Myanmar
|
83.00 % | 2019 | +1.2 % | +0.7 % | View data | |
| 72 |
#72
Sri Lanka
|
83.00 % | 2019 | +2.5 % | +3.8 % | View data | |